03.09.26 -- Unlock Smarter Strategies For End-To-End Biologics Manufacturing

Examine how continuous media exchange enables eight-fold increases in viable cell density and doubled protein productivity through targeted N-1 intensification. Understand the design principles, retention technologies, and systematic approaches that make extended high-density cultures feasible.

Learn how strategic small-scale downstream studies generate the process intelligence needed to accelerate biologics development, strengthen validation packages, and resolve manufacturing challenges before they impact clinical timelines.

Centralized engineering teams can transform operational feedback into standardized facility designs that deliver ≥99% batch success rates. Learn the mechanics of design review systems that codify improvements within two weeks and how plant equivalency enables rapid tech transfers across sites with minimal requalification.